RegulyzeCinnamon
Cinnamomum zeylanicum · Bark
Cinnamon (Cinnamomum zeylanicum) is a botanical permitted for use in nutraceuticals and health supplements under India's FSSAI framework, with a permitted limit of 1-2 g. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | 1-2 g | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Cinnamon
Cinnamon is tracked in the Regulyze Ingredient Intelligence database as a botanical (Cinnamomum zeylanicum). It is listed in India's FSSAI schedules under the regulatory name Twak / Dalchini. The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Cinnamon permitted in nutraceuticals under FSSAI (India)?
Cinnamon (Cinnamomum zeylanicum) (listed in the regulation as “Twak / Dalchini”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Cinnamon?
The permitted level recorded for Cinnamon is 1-2 g. Limits can vary by product type and market — confirm against the current regulation.
What product category does Cinnamon belong to?
Cinnamon is classified under: Botanicals.
What is the botanical (scientific) name of Cinnamon?
Cinnamon corresponds to Cinnamomum zeylanicum, with the bark used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.